Mixed
Roux-en-Y Gastric Bypass (RYGB) and Sleeve Gastrectomy (SG) are highly effective surgical interventions for severe obesity, with RYGB showing slightly greater long-term weight loss.
Surgical options like RYGB and SG are highly effective for severe obesity, leading to 47-55% excess weight loss over seven years. RYGB tends to result in slightly greater weight loss than SG, but both improve quality of life. These are major surgeries requiring careful patient selection and postoperative management.
Surgical techniques like Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) achieve 27–69% excess weight loss (EWL)... The mean percentage of excess weight loss (%EWL) after seven years was 47% (95% CI, 43%-50%) in the LSG group and 55% (95% CI, 52%-59%) in the LRYGB group, resulting in a difference of 8.7 percentage points (95% CI, 3.5-13.9) favoring LRYGB
Why this rating
Based on large-scale database analyses and randomized controlled trials (SLEEVEPASS).
Source
TRENDS IN OBESITY TREATMENT: A REVIEW OF THE LITERATURE FROM THE LAST SIX YEARS
Adam Sobiński et al. · International Journal of Innovative Technologies in Social Science · 2025
DOI 10.31435/ijitss.4(48).2025.4326
More from this paper
- Semaglutide (2.4 mg weekly) produces significant weight loss (approx. 15%) by acting as a GLP-1 receptor agonist that stimulates satiety centers in the hypothalamus.Strong
- Tirzepatide (5-15 mg weekly) produces dose-dependent weight loss (up to 25.3%) by acting as a dual GLP-1 and GIP receptor agonist.Strong
- Intragastric balloons (Obalon, Orbera, ReShape Duo) provide temporary weight loss (12-25% EWL) when combined with lifestyle modifications.Good
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →